Floatz logo

Therapeutic Asset Ratings

19,639 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cyclophosphamide
Hormone-Resistant Prostate Cancer
University of Wisconsin, MadisonP2BB (66)
Cyclophosphamide
Locally Advanced Malignant Solid Neoplasm
City of Hope Medical CenterP2BB (66)
Cyclophosphamide
Ovarian Clear Cell Adenocarcinoma
Roswell Park Cancer InstituteP2BB (66)
Cyclophosphamide
Ovarian Endometrioid Adenocarcinoma
Roswell Park Cancer InstituteP2BB (66)
Cyclophosphamide
Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP2BB (66)
Cyclophosphamide
Retinoblastoma
Seattle Children's HospitalP2BB (66)
Cyclophosphamide
Stage IV Bladder Cancer AJCC v8
Fred Hutchinson Cancer CenterP2BB (66)
Cyclophosphamide
Stage IV Ureter Cancer AJCC v8
Fred Hutchinson Cancer CenterP2BB (66)
Cyclophosphamide
Synovial Sarcoma
Zelluna Immunotherapy ASP2BB (66)
CYCLOSPORIN A
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer CenterP2BB (66)
Dalzanemdor
Cognitive Disorder
Supernus Pharmaceuticals, Inc.P2BB (66)
Dasatinib
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP2BB (66)
DEXAMETHASONE
Post-transplant Lymphoproliferative Disorder
Northwestern UniversityP2BB (66)
Docetaxel
Ovarian Neoplasm
Merck Sharp & Dohme LLCP2BB (66)
Durvalumab
Advanced Refractory Solid Tumors
Second Affiliated Hospital of Soochow UniversityP2BB (66)
Durvalumab
Estrogen-Receptor Positive Breast Cancer
National Taiwan University HospitalP2BB (66)
Durvalumab
Malignant Pancreatic Neoplasm
Jonsson Comprehensive Cancer CenterP2BB (66)
Eloxatin
Bile Duct Cancer
Lisata Therapeutics, Inc.P2BB (66)
Eloxatin
Primary Mediastinal Large B-Cell Lymphoma
City of Hope Medical CenterP2BB (66)
Eloxatin
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
GenmabP2BB (66)
Eloxatin
Small Lymphocytic Lymphoma
City of Hope Medical CenterP2BB (66)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Renal Pelvis/Ureter Urothelial Carcinoma
National Cancer Institute (NCI)P2BB (66)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Urinary Bladder Cancer
Fred Hutchinson Cancer CenterP2BB (66)
Epirubicin
Melanoma and Other Malignant Neoplasms of Skin
Institute of Oncology LjubljanaP2BB (66)
Epirubicin
Metastatic Head and Neck Carcinoma
National Cancer Institute (NCI)P2BB (66)
Showing 601 to 625 of 19,639 assets
PreviousPage 25 of 786Next